- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有23家主力机构披露2024-12-31报告期持股数据，持仓量总计2.09亿股，占流通A股50.91%
- 波段诊断：
-
技术面诊股
诊断结果：2.2技术面打败了10%的股票
技术面评分前10的股票
近期的平均成本为7.38元。
平均成本
近期的平均成本为7.38元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.38","date":1751357419,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.07.02","stock":"-2.13","trade":"-1.57","ind":"-0.61"},{"date":"2025.07.01","stock":"2.17","trade":"2.52","ind":"0.11"},{"date":"2025.06.30","stock":"1.24","trade":"1.47","ind":"0.83"},{"date":"2025.06.27","stock":"-2.28","trade":"0.85","ind":"0.34"},{"date":"2025.06.26","stock":"1.36","trade":"-1.31","ind":"-0.48"},{"date":"2025.06.25","stock":"-0.54","trade":"0.29","ind":"1.72"},{"date":"2025.06.24","stock":"0.14","trade":"1.81","ind":"1.68"},{"date":"2025.06.23","stock":"3.95","trade":"1.50","ind":"0.43"},{"date":"2025.06.20","stock":"-3.14","trade":"0.27","ind":"-0.47"},{"date":"2025.06.19","stock":"-1.48","trade":"-1.80","ind":"-1.21"},{"date":"2025.06.18","stock":"0.27","trade":"-1.20","ind":"0.24"},{"date":"2025.06.17","stock":"-2.50","trade":"-1.63","ind":"-0.12"},{"date":"2025.06.16","stock":"1.60","trade":"-0.12","ind":"0.41"},{"date":"2025.06.13","stock":"-4.71","trade":"-2.82","ind":"-1.10"},{"date":"2025.06.12","stock":"-2.97","trade":"1.54","ind":"-0.11"},{"date":"2025.06.11","stock":"-2.29","trade":"-1.03","ind":"0.83"},{"date":"2025.06.10","stock":"-1.31","trade":"1.10","ind":"-0.86"},{"date":"2025.06.09","stock":"2.07","trade":"2.75","ind":"0.65"},{"date":"2025.06.06","stock":"1.23","trade":"0.34","ind":"-0.19"},{"date":"2025.06.05","stock":"-4.69","trade":"-1.02","ind":"0.58"},{"date":"2025.06.04","stock":"4.03","trade":"0.26","ind":"0.87"}]
*ST双成,深证成指,生物制品指数
压力支撑
该股压力位为7.39元，支撑位为7.30元。
[{"text":"\u538b\u529b\u4f4d","value":"7.39","date":1751385600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.30","date":1751385600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.7资金面打败了79%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月03日 08:10
| 机构今日流向(万元) | -2510.04 | 机构5日流向(万元) | -3150.27 |
| 机构10日流向(万元) | -5023.90 | 机构20日流向(万元) | -19061.97 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量增加775.38万股，其中基金净减仓1家，主力净增仓11家，请投资者中长期谨慎为宜。
截止2024-12-31，共23家主力机构（基金18家，QFII2家，一般法人3家），持仓量总计20936.04万股，占流通A股50.91%
其中，基金持仓与2024-06-30相比：
增仓：1家 ，增持 1.29万股
减仓：2家 ，减持 0.32万股
新出现在主力名单中：16家 ，持有798.04万股
从主力名单中消失：5家 ，原持有23.63万股
其中，基金持仓与2024-06-30相比：
增仓：1家 ，增持 1.29万股
减仓：2家 ，减持 0.32万股
新出现在主力名单中：16家 ，持有798.04万股
从主力名单中消失：5家 ，原持有23.63万股
消息面诊股
诊断结果：5.4消息面打败了20%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 翻倍股频出！这一板块，“七连阳”
2025-07-01 - 重组概念“妖股”频现！私募游资提前埋伏，有前十大股
2025-06-30 - 重组效率提高！有重大资产重组用时仅3个月，跨界并购
2025-06-20 - 券商观点|医药生物行业周报：药品、耗材集采有望优化
2025-06-16 - *ST双成：美国产品销售利润分成将按协议正常执行
2025-06-12 - *ST双成：公司目前没有创新药在研
2025-06-11 - 中美白蛋白紫杉醇仿制药竞争格局：双成药业三适应症突
2025-06-04 - *ST双成：公司已累计收到HKF支付的里程碑款项3
2025-06-03 - 四年走出“冷宫”：多只医药股翻倍涨，创新药基金收益
2025-05-28 - 涨停雷达：多肽药物+FDA批准+ST板块 *ST双
2025-05-28
消息列表
| 一般消息 | 高管变动 | 因公司组织架构调整原因 | 2025-06-20 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-06-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-10 |
| 利空 | 上市变动 | 特别处理*ST | 2025-04-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-22 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-11 |
| 重大利空 | 业绩预告 | 预计增亏 | 2025-01-18 |
| 利空 | 股票增发 | 停止实施 | 2024-09-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-07-16 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 3条 | 1条 | 2条 |
行业面诊股
诊断结果：7.2行业面打败了91%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.07.02","price":"-0.61","value":"-1.57"},{"date":"2025.07.01","price":"0.11","value":"2.52"},{"date":"2025.06.30","price":"0.83","value":"1.47"},{"date":"2025.06.27","price":"0.34","value":"0.85"},{"date":"2025.06.26","price":"-0.48","value":"-1.31"},{"date":"2025.06.25","price":"1.72","value":"0.29"},{"date":"2025.06.24","price":"1.68","value":"1.81"},{"date":"2025.06.23","price":"0.43","value":"1.50"},{"date":"2025.06.20","price":"-0.47","value":"0.27"},{"date":"2025.06.19","price":"-1.21","value":"-1.80"},{"date":"2025.06.18","price":"0.24","value":"-1.20"},{"date":"2025.06.17","price":"-0.12","value":"-1.63"},{"date":"2025.06.16","price":"0.41","value":"-0.12"},{"date":"2025.06.13","price":"-1.10","value":"-2.82"},{"date":"2025.06.12","price":"-0.11","value":"1.54"},{"date":"2025.06.11","price":"0.83","value":"-1.03"},{"date":"2025.06.10","price":"-0.86","value":"1.10"},{"date":"2025.06.09","price":"0.65","value":"2.75"},{"date":"2025.06.06","price":"-0.19","value":"0.34"},{"date":"2025.06.05","price":"0.58","value":"-1.02"},{"date":"2025.06.04","price":"0.87","value":"0.26"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 神州细胞 | 42.21% | 7.80% | 5.8分 |
| 2 | 百普赛斯 | 32.13% | 20.91% | 5.9分 |
| 3 | 赛升药业 | 30.26% | 1.86% | 4.6分 |
| 4 | 未名医药 | 19.06% | 8.58% | 4.7分 |
| 5 | 迈威生物 | 17.58% | 13.06% | 4.6分 |
| 6 | *ST四环 | 12.79% | -6.08% | 4.4分 |
| 8 | 康华生物 | 7.50% | -1.81% | 4.9分 |
| 10 | 通化东宝 | 6.86% | 3.32% | 5.6分 |
| 12 | 义翘神州 | 5.80% | 3.06% | 5.4分 |
| 14 | 近岸蛋白 | 5.15% | 7.26% | 4.7分 |
| 16 | 康泰生物 | 3.57% | -1.44% | 4.7分 |
| 18 | 万泽股份 | 3.07% | 6.88% | 6.3分 |
| 20 | 我武生物 | 1.71% | 4.39% | 5.2分 |
| 22 | 诺诚健华 | 1.43% | 4.01% | 4.2分 |
| 24 | 华兰疫苗 | 1.08% | 1.94% | 5.1分 |
| 26 | 天坛生物 | 0.05% | -0.21% | 5.0分 |
| 28 | 甘李药业 | -0.14% | 3.11% | 5.3分 |
| 30 | 百克生物 | -0.62% | 0.29% | 5.0分 |
| 32 | 诺唯赞 | -1.24% | 1.04% | 5.2分 |
| 34 | 康希诺 | -1.88% | -1.49% | 4.2分 |
| 36 | 卫光生物 | -2.26% | 1.72% | 5.2分 |
| 38 | 西藏药业 | -3.28% | -0.25% | 4.8分 |
| 40 | 博雅生物 | -4.54% | -0.92% | 4.8分 |
| 42 | 安科生物 | -4.86% | 2.62% | 5.9分 |
| 44 | 昊帆生物 | -5.74% | 2.40% | 4.7分 |
| 46 | 长春高新 | -8.42% | -0.10% | 5.0分 |
| 48 | 欧林生物 | -10.99% | 0.51% | 5.2分 |
| 50 | *ST双成 | -13.62% | 0.27% | 4.9分 |
| 52 | 科兴制药 | -16.24% | 17.28% | 5.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：一般，低于行业平均，两项指标的行业排名分别为 45/72 ， 41/72。
[{"date":"2025-03-31","value":"-2.59","vol":"0.63"},{"date":"2024-12-31","value":"-18.11","vol":"-0.24"},{"date":"2024-09-30","value":"-8.36","vol":"1.37"},{"date":"2024-06-30","value":"-3.66","vol":"0.72"},{"date":"2024-03-31","value":"-1.87","vol":"0.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.59 | -18.11 | -8.36 | -3.66 | -1.87 |
| 行业(%) | 0.63 | -0.24 | 1.37 | 0.72 | 0.41 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"49.57","vol":"69.78"},{"date":"2024-12-31","value":"56.04","vol":"69.97"},{"date":"2024-09-30","value":"59.95","vol":"70.57"},{"date":"2024-06-30","value":"61.76","vol":"69.89"},{"date":"2024-03-31","value":"60.06","vol":"70.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.57 | 56.04 | 59.95 | 61.76 | 60.06 |
| 行业(%) | 69.78 | 69.97 | 70.57 | 69.89 | 70.42 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 37/72 ， 31/72。
[{"date":"2025-03-31","value":"-14.23","vol":"6246.12"},{"date":"2024-12-31","value":"-26.16","vol":"48.20"},{"date":"2024-09-30","value":"-30.34","vol":"178.44"},{"date":"2024-06-30","value":"-31.74","vol":"19.75"},{"date":"2024-03-31","value":"-47.52","vol":"31.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.23 | -26.16 | -30.34 | -31.74 | -47.52 |
| 行业(%) | 6246.12 | 48.20 | 178.44 | 19.75 | 31.66 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-14.84","vol":"-7.36"},{"date":"2024-12-31","value":"-54.32","vol":"-10.38"},{"date":"2024-09-30","value":"-2234.84","vol":"-53.42"},{"date":"2024-06-30","value":"-292.78","vol":"-9.25"},{"date":"2024-03-31","value":"-294.04","vol":"-535.57"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-14.84 | -54.32 | -2234.84 | -292.78 | -294.04 |
| 行业(%) | -7.36 | -10.38 | -53.42 | -9.25 | -535.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 28/72 ， 19/72。
[{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.22","vol":"0.29"},{"date":"2024-09-30","value":"0.16","vol":"0.22"},{"date":"2024-06-30","value":"0.12","vol":"0.14"},{"date":"2024-03-31","value":"0.05","vol":"0.07"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.05 | 0.22 | 0.16 | 0.12 | 0.05 |
| 行业(次) | 0.06 | 0.29 | 0.22 | 0.14 | 0.07 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.24","vol":"0.26"},{"date":"2024-12-31","value":"0.99","vol":"1.19"},{"date":"2024-09-30","value":"0.65","vol":"0.87"},{"date":"2024-06-30","value":"0.50","vol":"0.55"},{"date":"2024-03-31","value":"0.23","vol":"0.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.24 | 0.99 | 0.65 | 0.50 | 0.23 |
| 行业(次) | 0.26 | 1.19 | 0.87 | 0.55 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-13.19","vol":"-47.52"},{"date":"2024-12-31","value":"-44.70","vol":"-9.01"},{"date":"2024-09-30","value":"11.84","vol":"-29.47"},{"date":"2024-06-30","value":"0.26","vol":"-36875.39"},{"date":"2024-03-31","value":"-55.28","vol":"-44804.94"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -13.19 | -44.70 | 11.84 | 0.26 | -55.28 |
| 行业 | -47.52 | -9.01 | -29.47 | -36875.39 | -44804.94 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.45","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.78","vol":"2.72"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.45 | - | 0.78 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.72 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 19/72 ， 18/72。
[{"date":"2025-03-31","value":"0.80","vol":"7.90"},{"date":"2024-12-31","value":"0.88","vol":"6.83"},{"date":"2024-09-30","value":"1.00","vol":"7.16"},{"date":"2024-06-30","value":"1.08","vol":"7.04"},{"date":"2024-03-31","value":"1.01","vol":"8.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.80 | 0.88 | 1.00 | 1.08 | 1.01 |
| 行业 | 7.90 | 6.83 | 7.16 | 7.04 | 8.08 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.32","vol":"6.47"},{"date":"2024-12-31","value":"0.41","vol":"5.50"},{"date":"2024-09-30","value":"0.47","vol":"5.77"},{"date":"2024-06-30","value":"0.56","vol":"5.91"},{"date":"2024-03-31","value":"0.40","vol":"6.93"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.32 | 0.41 | 0.47 | 0.56 | 0.40 |
| 行业 | 6.47 | 5.50 | 5.77 | 5.91 | 6.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 3/72 ， 7/72。
[{"date":"2025-03-31","value":"47.77","vol":"25.48"},{"date":"2024-12-31","value":"47.49","vol":"25.46"},{"date":"2024-09-30","value":"43.45","vol":"24.92"},{"date":"2024-06-30","value":"39.79","vol":"24.62"},{"date":"2024-03-31","value":"36.92","vol":"23.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
47.77 | 47.49 | 43.45 | 39.79 | 36.92 |
| 行业(%) | 25.48 | 25.46 | 24.92 | 24.62 | 23.98 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.95","vol":"0.78"},{"date":"2024-12-31","value":"0.95","vol":"0.88"},{"date":"2024-09-30","value":"0.83","vol":"0.41"},{"date":"2024-06-30","value":"0.72","vol":"0.38"},{"date":"2024-03-31","value":"0.64","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.95 | 0.95 | 0.83 | 0.72 | 0.64 |
| 行业(%) | 0.78 | 0.88 | 0.41 | 0.38 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"-0.20","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.78","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]